Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2005 3
2006 7
2007 8
2008 12
2009 7
2010 8
2011 5
2012 8
2013 12
2014 5
2015 6
2016 4
2017 2
2018 2
2019 5
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 18474889

85 results
Results by year
Filters applied: . Clear all
Page 1
Effect of nonergot dopamine agonists on symptoms of restless legs syndrome.
Baker WL, White CM, Coleman CI. Baker WL, et al. Ann Fam Med. 2008 May-Jun;6(3):253-62. doi: 10.1370/afm.845. Ann Fam Med. 2008. PMID: 18474889 Free PMC article. Review.
Effect of non-ergot dopamine agonists on health-related quality of life of patients with restless legs syndrome.
Talati R, Phung OJ, Mather J, Coleman CI. Talati R, et al. Ann Pharmacother. 2009 May;43(5):813-21. doi: 10.1345/aph.1L673. Epub 2009 Apr 28. Ann Pharmacother. 2009. PMID: 19401472
Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Liu GJ, Wu L, Lin Wang S, Xu LL, Ying Chang L, Fu Wang Y. Liu GJ, et al. Clin Ther. 2016 Jan 1;38(1):162-179.e6. doi: 10.1016/j.clinthera.2015.10.010. Epub 2015 Nov 11. Clin Ther. 2016. PMID: 26572941 Free PMC article. Review.
Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
VanMeter SA, Kavanagh ST, Warren S, Barrett RW. VanMeter SA, et al. CNS Drugs. 2012 Sep 1;26(9):773-80. doi: 10.2165/11634870-000000000-00000. CNS Drugs. 2012. PMID: 22849331
Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
Allen R, Oertel W, Walters A, Benes H, Schollmayer E, Grieger F, Moran K, Kohnen R. Allen R, et al. Sleep Med. 2013 Dec;14(12):1375-80. doi: 10.1016/j.sleep.2013.09.008. Epub 2013 Oct 18. Sleep Med. 2013. PMID: 24246378 Clinical Trial.
A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.
Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW; XP053 Study Group. Lee DO, et al. J Clin Sleep Med. 2011 Jun 15;7(3):282-92. doi: 10.5664/JCSM.1074. J Clin Sleep Med. 2011. PMID: 21677899 Free PMC article. Clinical Trial.
Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
Giorgi L, Asgharian A, Hunter B. Giorgi L, et al. Clin Ther. 2013 Sep;35(9):1321-36. doi: 10.1016/j.clinthera.2013.06.016. Epub 2013 Aug 9. Clin Ther. 2013. PMID: 23938061 Clinical Trial.
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial.
Trenkwalder C, Benes H, Poewe W, Oertel WH, Garcia-Borreguero D, de Weerd AW, Ferini-Strambi L, Montagna P, Odin P, Stiasny-Kolster K, Högl B, Chaudhuri KR, Partinen M, Schollmayer E, Kohnen R; SP790 Study Group. Trenkwalder C, et al. Lancet Neurol. 2008 Jul;7(7):595-604. doi: 10.1016/S1474-4422(08)70112-1. Lancet Neurol. 2008. PMID: 18515185 Clinical Trial.
Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
Quilici S, Abrams KR, Nicolas A, Martin M, Petit C, Lleu PL, Finnern HW. Quilici S, et al. Sleep Med. 2008 Oct;9(7):715-26. doi: 10.1016/j.sleep.2007.11.020. Epub 2008 Jan 28. Sleep Med. 2008. PMID: 18226947
Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis.
Wilt TJ, MacDonald R, Ouellette J, Khawaja IS, Rutks I, Butler M, Fink HA. Wilt TJ, et al. JAMA Intern Med. 2013 Apr 8;173(7):496-505. doi: 10.1001/jamainternmed.2013.3733. JAMA Intern Med. 2013. PMID: 23460396 Review.
85 results
Jump to page
Feedback